Doctors: FDA Threatens Strategy To Manage High-Risk Pregnancies
MANAGED CARE May 1998. ©1998 Stezzi Communications A group of physicians calling itself the “Terbutaline Strategy Group” has petitioned the U.S. Food and Drug Administration to reverse itself, after the agency mailed a “Dear Colleague” letter warning practitioners about use of terbutaline sulfate for prevention of preterm labor. The doctors worry that the FDA action could remove … Read more